Do infectious diseases after kidney re-transplantation differ from those after first kidney transplantation?

K. Kusejko, D. Neofytos, C. van Delden, H. Hirsch, Pascal Meylan, K. Boggian, Cédric Hirzel, C. Garzoni, D. Sidler, A. Schnyder, S. Schaub, D. Golshayan, Fadi Haidar, M. Bonani, R. Kouyos, N. J. Mueller, P. Schreiber, P. Amico, John-David Aubert, V. Banz, S. Beckmann, G. Beldi, C. Berger, E. Berishvili, A. Berzigotti, I. Binet, P. Bochud, S. Branca, H. Bucher, E. Catana, A. Cairoli, Y. Chalandon, S. de Geest, O. de Rougemont, S. de Seigneux, M. Dickenmann, J. Dreifuss, M. Duchosal, T. Fehr, S. Ferrari-Lacraz, C. Garzoni, D. Golshayan, N. Goossens, F. H. J. Halter, D. Heim, C. Hess, S. Hillinger, H. Hirsch, P. Hirt, G. Hofbauer, U. Huynh-Do, F. Immer, M. Koller, M. Laager, B. Laesser, F. Lamoth, R. Lehmann, A. Leichtle, O. Manuel, H. Marti, M. Martinelli, V. McLin, K. Mellac, A. Merçay, K. Mettler, A. Müller, N. J. Mueller, U. Müller-Arndt, B. Müllhaupt, M. Nägeli, G. Oldani, M. Pascual, J. Passweg, R. Pazeller, K. Posfay-Barbe, J. Rick, A. Rosselet, S. Rossi, S. Rothlin, F. Ruschitzka, T. Schachtner, U. S
{"title":"Do infectious diseases after kidney re-transplantation differ from those after first kidney transplantation?","authors":"K. Kusejko, D. Neofytos, C. van Delden, H. Hirsch, Pascal Meylan, K. Boggian, Cédric Hirzel, C. Garzoni, D. Sidler, A. Schnyder, S. Schaub, D. Golshayan, Fadi Haidar, M. Bonani, R. Kouyos, N. J. Mueller, P. Schreiber, P. Amico, John-David Aubert, V. Banz, S. Beckmann, G. Beldi, C. Berger, E. Berishvili, A. Berzigotti, I. Binet, P. Bochud, S. Branca, H. Bucher, E. Catana, A. Cairoli, Y. Chalandon, S. de Geest, O. de Rougemont, S. de Seigneux, M. Dickenmann, J. Dreifuss, M. Duchosal, T. Fehr, S. Ferrari-Lacraz, C. Garzoni, D. Golshayan, N. Goossens, F. H. J. Halter, D. Heim, C. Hess, S. Hillinger, H. Hirsch, P. Hirt, G. Hofbauer, U. Huynh-Do, F. Immer, M. Koller, M. Laager, B. Laesser, F. Lamoth, R. Lehmann, A. Leichtle, O. Manuel, H. Marti, M. Martinelli, V. McLin, K. Mellac, A. Merçay, K. Mettler, A. Müller, N. J. Mueller, U. Müller-Arndt, B. Müllhaupt, M. Nägeli, G. Oldani, M. Pascual, J. Passweg, R. Pazeller, K. Posfay-Barbe, J. Rick, A. Rosselet, S. Rossi, S. Rothlin, F. Ruschitzka, T. Schachtner, U. S","doi":"10.1093/ofid/ofae055","DOIUrl":null,"url":null,"abstract":"\n \n \n Infectious diseases (ID) are highly relevant after solid organ transplantation in terms of morbidity and mortality, being among the most common causes of death. Patients undergoing kidney re-transplantation (re-K-Tx) have been already receiving immunosuppressive therapy over a prolonged period potentially facilitating subsequent infections. Comparing ID events after re-K-Tx and first kidney transplantation (f-K-Tx) can delineate patterns and risks of ID events associated with prolonged immunosuppression.\n \n \n \n We included adult patients with records on the f-K-Tx and re-K-Tx in the Swiss Transplant Cohort Study. We analyzed ID events after f-K-Tx and re-K-Tx within the same patients, and compared infection rates, causative pathogens and infection sites. Recurrent time to event analyses were performed for comparison of infection rates.\n \n \n \n A total of 59 patients with a median age of 47 years (range = 18 - 73) were included. Overall, 312 ID events in 52 patients occurred. In multivariable recurrent event modelling, the rate of ID events was significantly lower after re-K-Tx (HR = 0.70, p = 0.02). More bacterial (68.9% versus 60.4%) and fungal (4.0% versus 1.1%) infections were observed after f-K-Tx, but less viral infections (27.0% versus 38.5%) as compared to after re-K-Tx (p = 0.11). After f-K-Tx, urinary tract and gastrointestinal tract infections were more frequent; after re-K-Tx, respiratory tract and surgical site infections were more frequent (p < 0.001).\n \n \n \n Infectious disease events were less frequent after re-K-Tx. Affected sites differed significantly after f-K-Tx compared to after re-K-Tx.\n","PeriodicalId":510506,"journal":{"name":"Open Forum Infectious Diseases","volume":"124 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ofid/ofae055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Infectious diseases (ID) are highly relevant after solid organ transplantation in terms of morbidity and mortality, being among the most common causes of death. Patients undergoing kidney re-transplantation (re-K-Tx) have been already receiving immunosuppressive therapy over a prolonged period potentially facilitating subsequent infections. Comparing ID events after re-K-Tx and first kidney transplantation (f-K-Tx) can delineate patterns and risks of ID events associated with prolonged immunosuppression. We included adult patients with records on the f-K-Tx and re-K-Tx in the Swiss Transplant Cohort Study. We analyzed ID events after f-K-Tx and re-K-Tx within the same patients, and compared infection rates, causative pathogens and infection sites. Recurrent time to event analyses were performed for comparison of infection rates. A total of 59 patients with a median age of 47 years (range = 18 - 73) were included. Overall, 312 ID events in 52 patients occurred. In multivariable recurrent event modelling, the rate of ID events was significantly lower after re-K-Tx (HR = 0.70, p = 0.02). More bacterial (68.9% versus 60.4%) and fungal (4.0% versus 1.1%) infections were observed after f-K-Tx, but less viral infections (27.0% versus 38.5%) as compared to after re-K-Tx (p = 0.11). After f-K-Tx, urinary tract and gastrointestinal tract infections were more frequent; after re-K-Tx, respiratory tract and surgical site infections were more frequent (p < 0.001). Infectious disease events were less frequent after re-K-Tx. Affected sites differed significantly after f-K-Tx compared to after re-K-Tx.
肾脏再移植后的感染性疾病与首次肾脏移植后的感染性疾病是否有所不同?
传染病(ID)与实体器官移植后的发病率和死亡率密切相关,是最常见的死亡原因之一。接受肾脏再移植(re-K-Tx)的患者已经长期接受免疫抑制治疗,这可能会促进后续感染的发生。比较再次肾移植(re-K-Tx)和首次肾移植(f-K-Tx)后的ID事件,可以确定与长期免疫抑制相关的ID事件的模式和风险。 我们纳入了瑞士移植队列研究(Swiss Transplant Cohort Study)中有 f-K-Tx 和 re-K-Tx 记录的成年患者。我们分析了同一患者在进行 f-K-Tx 和 re-K-Tx 后发生的 ID 事件,并比较了感染率、致病病原体和感染部位。为了比较感染率,我们还进行了复发时间分析。 共纳入 59 名患者,中位年龄为 47 岁(18 - 73 岁)。52名患者共发生了312例ID事件。在多变量复发事件模型中,重新进行 K-Tx 治疗后的 ID 事件发生率明显降低(HR = 0.70,P = 0.02)。f-K-Tx 后观察到的细菌感染(68.9% 对 60.4%)和真菌感染(4.0% 对 1.1%)更多,但病毒感染(27.0% 对 38.5%)少于 re-K-Tx 后(p = 0.11)。f-K-Tx 后,泌尿道和胃肠道感染更为频繁;re-K-Tx 后,呼吸道和手术部位感染更为频繁(p < 0.001)。 重新进行 K-Tx 治疗后,感染性疾病的发生率较低。f-K-Tx 与 re-K-Tx 相比,受影响的部位有很大不同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信